By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
New Jersey's Aerie Pharmaceuticals, Inc. (AERI) Grabs $125 Million Financing Commitment 9/9/2014 6:08:03 AM
Aerie Pharmaceuticals, Inc. (AERI) Initiates Phase 3 Safety-Only Registration Trial in Canada Of Rhopressa™ In Patients With Glaucoma 9/3/2014 12:34:31 PM
Aerie Pharmaceuticals, Inc. (AERI) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/7/2014 10:56:46 AM
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada 7/24/2014 1:02:16 PM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/23/2014 1:08:59 PM
Aerie Pharmaceuticals, Inc. (AERI) Initiates Phase 3 Registration Trials of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 7/15/2014 11:21:49 AM
Aerie Pharmaceuticals, Inc. (AERI) Expands Management Team, Names Michael McCleerey As Vice President, Marketing 7/8/2014 10:53:55 AM
Aerie Pharmaceuticals, Inc. (AERI) Soars As Combo Eye Drug Roclatan Performs Well In Phase 2b Trial; Stock Up +28.29% At Market Close (June 25, 2014) 6/25/2014 6:39:50 AM
Aerie Pharmaceuticals, Inc. (AERI) Names Craig R. Skenes As Vice President, Business Development 6/17/2014 1:29:04 PM
Aerie Pharmaceuticals, Inc. (AERI) Elects James Mazzo To The Company‚Äôs Board Of Directors 6/12/2014 8:50:57 AM
1234
//-->